current_datetime: '2019-11-28T00:00:00+01:00'
guidelines:
  1: HAS-BLED.v1
test_cases:
- id: All 0
  input:
    1:
      gt0003|Systolic: 150,mm[Hg]
      gt0005|CR Result mircomol/L: 199,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 7,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|

- id: Systolic, CR
  input:
    1:
      gt0003|Systolic: 170,mm[Hg]
      gt0005|CR Result mircomol/L: 201,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 7,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 1|local::at0015|Yes|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 2
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 1|local::at0015|Yes|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 1|local::at0004|Intermediate risk |
      gt0076|Bleeding risk per 100 patient-year: 1|local::at0016|(1.02-3.2%)|
      gt0077|Recommendation: 1|local::at0019|Anticoagulation can be considered|

- id: Renal, HT history
  input:
    1:
      gt0003|Systolic: 150,mm[Hg]
      gt0005|CR Result mircomol/L: 199,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 7,/wk
      gt0013|Hypertension History: 1|local::at0015|Yes|
      gt0014|Renal Disease: 1|local::at0015|Yes|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 1|local::at0015|Yes|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 2
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 1|local::at0015|Yes|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 1|local::at0004|Intermediate risk |
      gt0076|Bleeding risk per 100 patient-year: 1|local::at0016|(1.02-3.2%)|
      gt0077|Recommendation: 1|local::at0019|Anticoagulation can be considered|

- id: Both
  input:
    1:
      gt0003|Systolic: 160,mm[Hg]
      gt0005|CR Result mircomol/L: 201,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 7,/wk
      gt0013|Hypertension History: 1|local::at0015|Yes|
      gt0014|Renal Disease: 1|local::at0015|Yes|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 1|local::at0015|Yes|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 2
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 1|local::at0015|Yes|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 1|local::at0004|Intermediate risk |
      gt0076|Bleeding risk per 100 patient-year: 1|local::at0016|(1.02-3.2%)|
      gt0077|Recommendation: 1|local::at0019|Anticoagulation can be considered|

- id: Stroke, Major bleeding, elderly, INR, medication, consumes alcohol but no abuse history
  input:
    1:
      gt0003|Systolic: 160,mm[Hg]
      gt0005|CR Result mircomol/L: 201,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1939-06-30T07:55Z
      gt0011|Standard Drinks: 8,/wk
      gt0013|Hypertension History: 1|local::at0015|Yes|
      gt0014|Renal Disease: 1|local::at0015|Yes|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 1|local::at0015|Yes|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 1|local::at0015|Yes|
      gt0018|Labile INR: 1|local::at0015|Yes|
      gt0020|Medication Usage Predisposing to Bleeding: 1|local::at0015|Yes|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 1|local::at0015|Yes|
      gt0029|Age > 65: 1|local::at0015|Yes|
      gt0026|Stroke History: 1|local::at0015|Yes|
      gt0031|Alcohol or Drug Usage History: 1|local::at0015|Yes|
      gt0030|Medication Usage Predisposing to Bleeding: 1|local::at0015|Yes|
      gt0032|Total score: 8
      gt0028|Labile INR: 1|local::at0015|Yes|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 1|local::at0015|Yes|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 1|local::at0015|Yes|
      gt0062|Age: 80,a
      gt0075|HAS-BLED risk assessment: 2|local::at0006|High risk |
      gt0076|Bleeding risk per 100 patient-year: 2|local::at0017|(4.9-19.6%) |
      gt0077|Recommendation: 2|local::at0020|Alternatives to anticoagulation should be considered|

- id: Doesn't consume, but has history
  input:
    1:
      gt0003|Systolic: 160,mm[Hg]
      gt0005|CR Result mircomol/L: 201,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1939-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 1|local::at0015|Yes|
      gt0014|Renal Disease: 1|local::at0015|Yes|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 1|local::at0015|Yes|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 1|local::at0015|Yes|
      gt0018|Labile INR: 1|local::at0015|Yes|
      gt0020|Medication Usage Predisposing to Bleeding: 1|local::at0015|Yes|
      gt0021|Alcohol or Drug Usage History: 1|local::at0015|Yes|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 1|local::at0015|Yes|
      gt0029|Age > 65: 1|local::at0015|Yes|
      gt0026|Stroke History: 1|local::at0015|Yes|
      gt0031|Alcohol or Drug Usage History: 1|local::at0015|Yes|
      gt0030|Medication Usage Predisposing to Bleeding: 1|local::at0015|Yes|
      gt0032|Total score: 8
      gt0028|Labile INR: 1|local::at0015|Yes|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 1|local::at0015|Yes|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 1|local::at0015|Yes|
      gt0062|Age: 80,a
      gt0075|HAS-BLED risk assessment: 2|local::at0006|High risk |
      gt0076|Bleeding risk per 100 patient-year: 2|local::at0017|(4.9-19.6%) |
      gt0077|Recommendation: 2|local::at0020|Alternatives to anticoagulation should be considered|

- id: Bilirubin
  input:
    1:
      gt0003|Systolic: 120,mm[Hg]
      gt0005|CR Result mircomol/L: 170,µmol/l
      gt0007|Total Bilirubin: 3,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 120,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|

- id: AST
  input:
    1:
      gt0003|Systolic: 120,mm[Hg]
      gt0005|CR Result mircomol/L: 170,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 120,U/l
      gt0048|AST Result: 145,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|

- id: ALP
  input:
    1:
      gt0003|Systolic: 120,mm[Hg]
      gt0005|CR Result mircomol/L: 170,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 120,U/l
      gt0042|ALP Result: 350,U/l
      gt0048|AST Result: 130,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|

- id: ALT
  input:
    1:
      gt0003|Systolic: 120,mm[Hg]
      gt0005|CR Result mircomol/L: 170,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 170,U/l
      gt0042|ALP Result: 200,U/l
      gt0048|AST Result: 130,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|

- id: Liver d history
  input:
    1:
      gt0003|Systolic: 120,mm[Hg]
      gt0005|CR Result mircomol/L: 170,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 1|local::at0015|Yes|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 160,U/l
      gt0042|ALP Result: 200,U/l
      gt0048|AST Result: 130,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|

- id: allneg
  input:
    1:
      gt0003|Systolic: 120,mm[Hg]
      gt0005|CR Result mircomol/L: 170,µmol/l
      gt0007|Total Bilirubin: 2,mg/dl
      gt0060|Birthdate: 1959-06-30T07:55Z
      gt0011|Standard Drinks: 1,/wk
      gt0013|Hypertension History: 0|local::at0014|No|
      gt0014|Renal Disease: 0|local::at0014|No|
      gt0015|Liver Disease: 0|local::at0014|No|
      gt0016|Stroke History: 0|local::at0014|No|
      gt0017|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0018|Labile INR: 0|local::at0014|No|
      gt0020|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0021|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0043|ALT Result: 160,U/l
      gt0042|ALP Result: 200,U/l
      gt0048|AST Result: 130,U/l
  expected_output:
    1:
      gt0024|Renal Disease: 0|local::at0014|No|
      gt0029|Age > 65: 0|local::at0014|No|
      gt0026|Stroke History: 0|local::at0014|No|
      gt0031|Alcohol or Drug Usage History: 0|local::at0014|No|
      gt0030|Medication Usage Predisposing to Bleeding: 0|local::at0014|No|
      gt0032|Total score: 0
      gt0028|Labile INR: 0|local::at0014|No|
      gt0027|Prior Major Bleeding or Predisposition to Bleeding: 0|local::at0014|No|
      gt0025|Liver Disease: 0|local::at0014|No|
      gt0023|Hypertension History: 0|local::at0014|No|
      gt0062|Age: 60,a
      gt0075|HAS-BLED risk assessment: 0|local::at0003|Low risk |
      gt0076|Bleeding risk per 100 patient-year: 0|local::at0015|(0.6-1.13%)|
      gt0077|Recommendation: 0|local::at0018|Anticoagulation should be considered|
